INTERNATIONAL PATENT: UNIVERSITE DE BORDEAUX, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE FILES APPLICATION FOR "COMBINATION COMPRISING AT LEAST ONE 5-HT2A RECEPTOR ANTAGONIST AND AT LEAST ONE 5-HT3 RECEPTOR ANTAGONIST AND ITS MEDICAL USE"

GENEVA, April 27 -- UNIVERSITE DE BORDEAUX (35 place Pey Berland33000 Bordeaux), INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (101 rue de Tolbiac75013 Paris), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (3 rue Michel Ange75016 Paris) filed a patent application (PCT/EP2025/079476) for "COMBINATION COMPRISING AT LEAST ONE 5-HT2A RECEPTOR ANTAGONIST AND AT LEAST ONE 5-HT3 RECEPTOR ANTAGONIST AND ITS MEDICAL USE" on Oct 13, 2025. With publication no. WO/2026/082658, the details related to the patent application was published on Apr 23, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s)...